• Nonivamide: TRPV1 Assay Design Beyond Cell Killing

  2026-08-17

  Nonivamide, a capsaicin analog and TRPV1 agonist, connects calcium-channel pharmacology with cancer cell growth inhibition and neuroimmune assay design. This guide focuses on experimental decision-making, solvent controls, pathway-specific readouts, and the translational limits of moving between tumor and inflammation models.

• DIDS: From Chloride Biology to Translational Strategy

  2026-08-16

  DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid) is more than a conventional chloride transport probe. This thought-leadership article examines how its ion-transport activity can support rigorous studies of cell stress, metastasis, vascular physiology, and translational assay design while emphasizing selectivity, chemical handling, and orthogonal validation.

• MK-571 (L-660,711) Assay Workflow Guide

  2026-08-15

  MK-571 (L-660,711) supports two complementary research strategies: blocking cysteinyl leukotriene signaling in airway models and probing ABCC1/MRP1-linked drug transport in macrophages. This workflow guide shows how to exploit its pharmacology while avoiding misattribution between receptor and transporter effects.

• ω-Agatoxin IVA and Excitotoxicity in Cortical Neurons

  2026-08-14

  The 1996 reference study tested whether blocking P- and Q-type calcium channels with omega-agatoxin IVA could prevent excitotoxic injury in cultured cortical neurons. Despite its established ability to inhibit calcium-dependent glutamate release, the toxin did not reduce LDH-defined injury caused by veratridine, ouabain, or NMDA, showing that suppression of presynaptic release does not necessarily produce neuroprotection.

• Mechanical Stress, Cytoskeleton, and Autophagy

  2026-08-14

  The reference study provides direct evidence that microfilaments are central to autophagy induced by cellular compression, while microtubules make a supporting contribution. Its combination of cytoskeletal perturbation, fluorescence-based analysis, and western blotting clarifies how mechanical inputs may be converted into degradative responses.

• HyperPFU™ High-Fidelity DNA Polymerase Guide

  2026-08-13

  HyperPFU™ high-fidelity DNA polymerase is intended for accurate amplification of long, GC-rich, inhibitor-affected, or otherwise difficult DNA templates. It produces blunt-ended products for cloning and sequencing workflows, but it is not the appropriate choice when 3′-A overhangs or sticky ends are required.

• Molecular Basis of TRPM3 Regulation by Neurosteroids

  2026-08-13

  The reference study combines cryo-electron microscopy, electrophysiology, molecular dynamics, and biochemical analysis to define how pregnenolone sulfate, CIM 0216, and primidone regulate TRPM3. Its structures connect ligand recognition with channel gating and disease-associated gain-of-function mutations, providing a mechanistic framework for studying TRPM3 in pain and neurodevelopmental disease.

• Tetrandrine Workflows for Ion Channel Research

  2026-08-12

  Tetrandrine enables a practical bridge from calcium-channel assays to inflammation, neuroscience, and exploratory structure-based screening. This workflow emphasizes DMSO handling, orthogonal validation, assay controls, and clear limits when translating a natural-product signal into mechanism.

• Sex Differences in Cannabinoid Withdrawal Behaviors

  2026-08-12

  Brewer and colleagues show that withdrawal from chronic WIN 55,212-2 exposure produces qualitatively different somatic and anxiety-like behavioral profiles in male and female rats. The study highlights why sex, withdrawal timing, antagonist dose, and locomotor controls must be integrated when modeling synthetic cannabinoid dependence.

• CBD and the Multidimensional Biology of Orofacial Pain

  2026-08-11

  This 2026 study shows that cannabidiol reduces inflammatory pain while also improving anxiety-like, depression-like, and cognitive abnormalities in mouse models. Its main contribution is a mechanistic separation of peripheral CB2-linked anti-inflammatory effects from central CB1-associated modulation of pain processing and serotonin dynamics.

• TAK-242 Workflows for TLR4 Inflammation Studies

  2026-08-11

  Build cleaner LPS challenge assays, neuroinflammation studies, and immune-oncology controls with TAK-242 (Resatorvid). This workflow-focused guide shows how to separate ligand-specific biology from technical failure while using selective TLR4 signaling pathway modulation.

• Phosphatase Inhibitor Cocktail 1 for CD59 Signaling

  2026-08-10

  Learn how Phosphatase Inhibitor Cocktail 1 supports phosphorylation-state preservation when studying the CD59–JAK2–STAT3 axis in pancreatic cancer. This assay-focused guide explains component coverage, workflow decisions, controls, and limitations beyond generic phosphoproteomics guidance.

• Capsaicin Workflows for TRPV1 and KDM1A Research

  2026-08-09

  Capsaicin, also called (E)-Capsaicin, connects rapid TRPV1 ion channel activation with reversible KDM1A/LSD1 inhibition. This guide turns that dual biology into practical workflows for sensory-neuron, inflammation, and gastric-cancer studies, with formulation controls and troubleshooting steps for reproducible results.

• 2'3'-cGAMP Beyond STING: A Translational Playbook

  2026-08-08

  2'3'-cGAMP is widely used as a direct STING activator, but emerging evidence suggests that its biology extends beyond canonical type I interferon signaling. This thought-leadership guide shows how translational researchers can use 2'3'-cGAMP (sodium salt) to separate STING-dependent effects from broader cGAMP biology, design more discriminating experiments, and build stronger hypotheses for immunotherapy research, cancer biology, inflammation, and antiviral studies.

• Proteoform-Specific Drug Targeting in Native Membranes

  2026-08-07

  Lutomski and colleagues developed a native mass-spectrometry workflow that releases membrane proteins and signaling complexes directly from retinal disc membranes, preserving proteoform-specific interaction information. The study shows how lipid modifications and proteoform identity influence G-protein assembly and the off-target binding of PDE5 inhibitors to retinal PDE6, providing a framework for more precise drug-discovery studies.

14812 records 1/988 page Next 12345 下5页 Last page